|
Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 103 seiten | |||||||||
| Inhalt der Studie: |
Introduction
GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Squamous Cell Carcinoma clinical trial scenario. This report pr.....
Introduction GlobalData's clinical trial report, “Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Squamous Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Highlights Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies [Studien Infos ausblenden] |
|||||||||||
|
Table of Contents Table of Contents 2 List of Tables 5 List of Figures 7 Introduction 8 Squamous Cell Carcinoma 8 Report Guidance 8 Clinical Trials by Region 9 Clinical Trials by Country 10 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12 Top Five Countries Contributing to Clinical Trials in Europe 13 Top Countries Contributing to Clinical Trials in North America 14 Top Countries Contributing to Clinical Trials in Middle East and Africa 15 Top Five Countries Contributing to Clinical Trials in Central and South America 16 Clinical Trials by BRIC Nations 17 Clinical Trials by G7 Nations 18 Clinical Trials in G7 Nations by Trial Status 19 Clinical Trials by E7 Nations 20 Clinical Trials in E7 Nations by Trial Status 21 Clinical Trials by Phase 22 In Progress Trials by Phase 23 Clinical Trials by Trial Status 24 Unaccomplished Trials of Squamous Cell Carcinoma 25 Subjects Recruited Over a Period of Time 29 Prominent Sponsors 30 Top Companies Participating in Squamous Cell Carcinoma Therapeutics Clinical Trials 32 Prominent Drug Comparison 34 Clinical Trial Profiles 35 Clinical Trial Overview of Top Companies 35 Amgen Inc. 35 Clinical Trial Overview of Amgen Inc. 35 Genmab A/S 36 Clinical Trial Overview of Genmab A/S 36 Boehringer Ingelheim GmbH 37 Clinical Trial Overview of Boehringer Ingelheim GmbH 37 Merck & Co., Inc. 38 Clinical Trial Overview of Merck & Co., Inc. 38 Pfizer Inc. 39 Clinical Trial Overview of Pfizer Inc. 39 Oncolytics Biotech Inc. 40 Clinical Trial Overview of Oncolytics Biotech Inc. 40 Cytotech ApS 41 Clinical Trial Overview of Cytotech ApS 41 Merrimack Pharmaceuticals, Inc. 42 Clinical Trial Overview of Merrimack Pharmaceuticals, Inc. 42 Nerviano Medical Sciences S.r.l. 43 Clinical Trial Overview of Nerviano Medical Sciences S.r.l. 43 Eisai Inc. 44 Clinical Trial Overview of Eisai Inc. 44 G&E Herbal Biotechnology Co., Ltd. 45 Clinical Trial Overview of G&E Herbal Biotechnology Co., Ltd. 45 Takara Bio Inc. 46 Clinical Trial Overview of Takara Bio Inc. 46 Clinuvel Pharmaceuticals Limited 47 Clinical Trial Overview of Clinuvel Pharmaceuticals Limited 47 Introgen Therapeutics, Inc. (Inactive) 48 Clinical Trial Overview of Introgen Therapeutics, Inc. (Inactive) 48 CEL-SCI Corporation 49 Clinical Trial Overview of CEL-SCI Corporation 49 Yakult Honsha Co., Ltd. 50 Clinical Trial Overview of Yakult Honsha Co., Ltd. 50 Galderma S.A. 51 Clinical Trial Overview of Galderma S.A. 51 Grifols, S.A. 52 Clinical Trial Overview of Grifols, S.A. 52 Eli Lilly and Company 53 Clinical Trial Overview of Eli Lilly and Company 53 Clinical Trial Overview of Top Universities / Institutes / Hospitals 54 The University of Texas M. D. Anderson Cancer Center 54 Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 54 European Organization for Research and Treatment of Cancer 56 Clinical Trial Overview of European Organization for Research and Treatment of Cancer 56 Memorial Sloan Kettering Cancer Center 58 Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 58 University of Pittsburgh 59 Clinical Trial Overview of University of Pittsburgh 59 University of Michigan Comprehensive Cancer Center 60 Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 60 Sun Yat-sen University 61 Clinical Trial Overview of Sun Yat-sen University 61 Samsung Medical Center 62 Clinical Trial Overview of Samsung Medical Center 62 Gynecologic Oncology Group 63 Clinical Trial Overview of Gynecologic Oncology Group 63 FUDAN University 64 Clinical Trial Overview of FUDAN University 64 Stanford University 65 Clinical Trial Overview of Stanford University 65 Massachusetts General Hospital 66 Clinical Trial Overview of Massachusetts General Hospital 66 Dana-Farber Cancer Institute 67 Clinical Trial Overview of Dana-Farber Cancer Institute 67 Sidney Kimmel Comprehensive Cancer Center 68 Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 68 Northwestern University 69 Clinical Trial Overview of Northwestern University 69 Mount Sinai School of Medicine 70 Clinical Trial Overview of Mount Sinai School of Medicine 70 Fred Hutchinson Cancer Research Center 71 Clinical Trial Overview of Fred Hutchinson Cancer Research Center 71 Ghent University Hospital 72 Clinical Trial Overview of Ghent University Hospital 72 Ohio State University Comprehensive Cancer Center 73 Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 73 University of California, Irvine 74 Clinical Trial Overview of University of California, Irvine 74 U.S. Department of Veterans Affairs 75 Clinical Trial Overview of U.S. Department of Veterans Affairs 75 Five Key Clinical Profiles 76 Appendix 99 Abbreviations 99 Definitions 99 Research Methodology 101 Secondary Research 101 About GlobalData 102 Contact Us 102 Disclaimer 102 Source 103 [Inhaltsverzeichnis ausblenden] |
||||||||||||
|
List of Tables Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12 Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13 Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012* 14 Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15 Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16 Squamous Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012* 17 Squamous Cell Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012* 18 Squamous Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Squamous Cell Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012* 20 Squamous Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Squamous Cell Carcinoma Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25 Squamous Cell Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26 Squamous Cell Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 31 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 33 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 35 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genmab A/S, 2012* 36 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 37 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 38 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 39 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2012* 40 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytotech ApS, 2012* 41 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merrimack Pharmaceuticals, Inc., 2012* 42 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nerviano Medical Sciences S.r.l., 2012* 43 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 44 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by G&E Herbal Biotechnology Co., Ltd., 2012* 45 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Takara Bio Inc., 2012* 46 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Clinuvel Pharmaceuticals Limited, 2012* 47 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Introgen Therapeutics, Inc. (Inactive), 2012* 48 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by CEL-SCI Corporation, 2012* 49 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Yakult Honsha Co., Ltd., 2012* 50 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Galderma S.A., 2012* 51 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012* 52 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 53 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 54 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 56 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 58 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 59 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 60 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 61 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2012* 62 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynecologic Oncology Group, 2012* 63 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 64 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 65 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2012* 66 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 67 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 68 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 69 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2012* 70 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 71 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2012* 72 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2012* 73 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2012* 74 Squamous Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2012* 75 List of Figures Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11 Squamous Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12 Squamous Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13 Squamous Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14 Squamous Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15 Squamous Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16 Squamous Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17 Squamous Cell Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012* 18 Squamous Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19 Squamous Cell Carcinoma Therapeutics Clinical Trials, E7 Countries (%), 2012* 20 Squamous Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23 Squamous Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 29 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32 Squamous Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 34 GlobalData Methodology 101 [Tabellenverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||
